S. T. Abedon, S. J. Kuhl, B. G. Blasdel, and E. M. Kutter, Phage treatment of human infections, Bacteriophage, vol.7, issue.2, pp.66-85, 2011.
DOI : 10.1016/S0041-1345(03)00525-6
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278644

D. A. Antonopoulos, S. M. Huse, H. G. Morrison, T. M. Schmidt, M. L. Sogin et al., Reproducible Community Dynamics of the Gastrointestinal Microbiota following Antibiotic Perturbation, Infection and Immunity, vol.77, issue.6, pp.2367-2375, 2009.
DOI : 10.1128/IAI.01520-08

M. Archambaud, P. Courcoux, V. Ouin, G. Chabanon, and A. Labigne-roussel, Phenotypic and genotypic assays for the detection and identification of adhesins from pyelonephritic Escherichia coli, Annales de l'Institut Pasteur / Microbiologie, vol.139, issue.5, pp.557-573, 1988.
DOI : 10.1016/0769-2609(88)90155-X

A. R. Brumbaugh and H. L. Mobley, vaccine, Expert Review of Vaccines, vol.11, issue.6, pp.663-676, 2012.
DOI : 10.1586/erv.12.36

A. Croswell, E. Amir, P. Teggatz, M. Barman, and N. H. Salzman, Prolonged Impact of Antibiotics on Intestinal Microbial Ecology and Susceptibility to Enteric Salmonella Infection, Infection and Immunity, vol.77, issue.7, pp.2741-2753, 2009.
DOI : 10.1128/IAI.00006-09

L. Debarbieux, Bacterial sensing of bacteriophages in communities: the search for the Rosetta stone, Current Opinion in Microbiology, vol.20, pp.125-130, 2014.
DOI : 10.1016/j.mib.2014.05.015

L. Debarbieux, D. Leduc, D. Maura, E. Morello, A. Criscuolo et al., Lung Infections, The Journal of Infectious Diseases, vol.201, issue.7, pp.1096-1104, 2010.
DOI : 10.1086/651135
URL : https://hal.archives-ouvertes.fr/pasteur-01425464

N. Dufour, L. Debarbieux, M. Fromentin, R. , and J. D. , Treatment of Highly Virulent Extraintestinal Pathogenic Escherichia coli Pneumonia With Bacteriophages*, Critical Care Medicine, vol.43, issue.6, pp.190-198, 2015.
DOI : 10.1097/CCM.0000000000000968

J. Furet, O. Firmesse, M. Gourmelon, C. Bridonneau, J. Tap et al., Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR, FEMS Microbiology Ecology, vol.68, issue.3, pp.351-362, 2009.
DOI : 10.1111/j.1574-6941.2009.00671.x

P. M. Grin, P. M. Kowalewska, W. Alhazzan, and A. E. Fox-robichaud, Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis, Can J Urol, vol.20, pp.6607-6614, 2013.

G. K. Harding, R. , and A. R. , The management of urinary infections; what have we learned in the past decade?, International Journal of Antimicrobial Agents, vol.4, issue.2, pp.83-88, 1994.
DOI : 10.1016/0924-8579(94)90038-8

T. H?-aussler, Viruses vs. Superbugs: A Solution to the Antibiotics Crisis, 2006.

T. J. Johnson, S. Kariyawasam, Y. Wannemuehler, P. Mangiamele, S. J. Johnson et al., The Genome Sequence of Avian Pathogenic Escherichia coli Strain O1:K1:H7 Shares Strong Similarities with Human Extraintestinal Pathogenic E. coli Genomes, Journal of Bacteriology, vol.189, issue.8, pp.3228-3236, 2007.
DOI : 10.1128/JB.01726-06

K. M. Keeney, S. Yurist-doutsch, M. C. Arrieta, and B. B. Finlay, Effects of Antibiotics on Human Microbiota and Subsequent Disease, Annual Review of Microbiology, vol.68, issue.1, pp.217-235, 2014.
DOI : 10.1146/annurev-micro-091313-103456

A. Lefort, X. Panhard, O. Clermont, P. L. Woerther, C. Branger et al., Host Factors and Portal of Entry Outweigh Bacterial Determinants To Predict the Severity of Escherichia coli Bacteremia, Journal of Clinical Microbiology, vol.49, issue.3, pp.777-783, 2011.
DOI : 10.1128/JCM.01902-10

D. Maura, M. Galtier, L. Bouguenec, C. Debarbieux, and L. , Virulent Bacteriophages Can Target O104:H4 Enteroaggregative Escherichia coli in the Mouse Intestine, Antimicrobial Agents and Chemotherapy, vol.56, issue.12, pp.6235-6242, 2012.
DOI : 10.1128/AAC.00602-12

D. Maura, E. Morello, L. Du-merle, P. Bomme, L. Bouguenec et al., Intestinal colonization by enteroaggregative Escherichia coli supports long-term bacteriophage replication in mice, Environmental Microbiology, vol.189, issue.8, pp.1844-1854, 2012.
DOI : 10.1111/j.1462-2920.2011.02644.x

S. Mccallin, A. Sarker, S. Barretto, C. Sultana, S. Berger et al., Safety analysis of a Russian phage cocktail: From MetaGenomic analysis to oral application in healthy human subjects, Virology, vol.443, issue.2, pp.187-196, 2013.
DOI : 10.1016/j.virol.2013.05.022

S. Minot, A. Bryson, C. Chehoud, G. D. Wu, J. D. Lewis et al., Rapid evolution of the human gut virome, Proceedings of the National Academy of Sciences, vol.29, issue.1, pp.12450-12455, 2013.
DOI : 10.1093/molbev/msr179

E. Morello, E. Saussereau, D. Maura, M. Huerre, L. Touqui et al., Pulmonary Bacteriophage Therapy on Pseudomonas aeruginosa Cystic Fibrosis Strains: First Steps Towards Treatment and Prevention, PLoS ONE, vol.72, issue.Pt 10, p.16963, 2011.
DOI : 10.1371/journal.pone.0016963.t001
URL : https://hal.archives-ouvertes.fr/pasteur-01425539

J. K. Nicholson, E. Holmes, J. Kinross, R. Burcelin, G. Gibson et al., Host-Gut Microbiota Metabolic Interactions, Science, vol.52, issue.6, pp.1262-1267, 2012.
DOI : 10.1099/ijs.0.02241-0
URL : https://hal.archives-ouvertes.fr/inserm-00726159

M. H. Nicolas-chanoine, X. Bertrand, and J. Y. Madec, Escherichia coli ST131, an Intriguing Clonal Group, Clinical Microbiology Reviews, vol.27, issue.3, pp.543-574, 2014.
DOI : 10.1128/CMR.00125-13
URL : https://hal.archives-ouvertes.fr/hal-01061609

J. M. Norman, S. A. Handley, M. T. Baldridge, L. Droit, C. Y. Liu et al., Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease, Cell, vol.160, issue.3, pp.447-460, 2015.
DOI : 10.1016/j.cell.2015.01.002

P. J. Parekh, L. A. Balart, J. , and D. A. , The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease, Clinical and Translational Gastroenterology, vol.491, issue.6, p.91, 2015.
DOI : 10.1016/j.chom.2014.02.007

D. Payros, T. Secher, M. Boury, C. Brehin, S. Menard et al., alters offspring?s intestinal homeostasis, Gut Microbes, vol.91, issue.3, pp.313-325, 2014.
DOI : 10.1038/nrmicro2245

E. Ruppe, B. Lixandru, R. Cojocaru, C. Buke, E. Paramythiotou et al., Relative Fecal Abundance of Extended-Spectrum-?-Lactamase-Producing Escherichia coli Strains and Their Occurrence in Urinary Tract Infections in Women, Antimicrobial Agents and Chemotherapy, vol.57, issue.9, pp.4512-4517, 2013.
DOI : 10.1128/AAC.00238-13

T. R. Sampson and S. K. Mazmanian, Control of Brain Development, Function, and Behavior by the Microbiome, Cell Host & Microbe, vol.17, issue.5, pp.565-576, 2015.
DOI : 10.1016/j.chom.2015.04.011

S. A. Sarker, S. Mccallin, C. Barretto, B. Berger, A. C. Pittet et al., Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh, Virology, vol.434, issue.2, pp.222-232, 2012.
DOI : 10.1016/j.virol.2012.09.002
URL : http://doi.org/10.1016/j.virol.2012.09.002

S. A. Sarker, S. Sultana, G. Reuteler, D. Moine, P. Descombes et al., Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh, EBioMedicine, vol.4, pp.124-137, 2016.
DOI : 10.1016/j.ebiom.2015.12.023

E. Saussereau, I. Vachier, R. Chiron, B. Godbert, I. Sermet et al., Effectiveness of bacteriophages in the sputum of cystic fibrosis patients, Clinical Microbiology and Infection, vol.20, issue.12, p.983, 2014.
DOI : 10.1111/1469-0691.12712

S. Takahashi, R. Hamasuna, M. Yasuda, S. Arakawa, K. Tanaka et al., A randomized clinical trial to evaluate the preventive effect of cranberry juice (UR65) for patients with recurrent urinary tract infection, Journal of Infection and Chemotherapy, vol.19, issue.1, pp.112-117, 2013.
DOI : 10.1007/s10156-012-0467-7

H. Tamaki, C. L. Wright, X. Li, Q. Lin, C. Hwang et al., Analysis of 16S rRNA Amplicon Sequencing Options on the Roche/454 Next-Generation Titanium Sequencing Platform, PLoS ONE, vol.37, issue.9, p.25263, 2011.
DOI : 10.1371/journal.pone.0025263.s001

P. K. Tosh and L. C. Mcdonald, Infection Control in the Multidrug-Resistant Era: Tending the Human Microbiome, Clinical Infectious Diseases, vol.54, issue.5, pp.707-713, 2012.
DOI : 10.1093/cid/cir899

M. Totsika, D. G. Moriel, A. Idris, B. A. Rogers, D. J. Wurpel et al., Uropathogenic Escherichia coli Mediated Urinary Tract Infection, Current Drug Targets, vol.13, issue.11, pp.1386-1399, 2012.
DOI : 10.2174/138945012803530206

C. Ubeda, V. Bucci, S. Caballero, A. Djukovic, N. C. Toussaint et al., Intestinal Microbiota Containing Barnesiella Species Cures Vancomycin-Resistant Enterococcus faecium Colonization, Infection and Immunity, vol.81, issue.3, pp.965-973, 2013.
DOI : 10.1128/IAI.01197-12
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584866

D. Vallenet, E. Belda, A. Calteau, S. Cruveiller, S. Engelen et al., MicroScope--an integrated microbial resource for the curation and comparative analysis of genomic and metabolic data, Nucleic Acids Research, vol.41, issue.D1, pp.636-647, 2013.
DOI : 10.1093/nar/gks1194

T. M. Viertel, K. Ritter, and H. P. Horz, Viruses versus bacteria--novel approaches to phage therapy as a tool against multidrug-resistant pathogens, Journal of Antimicrobial Chemotherapy, vol.69, issue.9, pp.2326-2336, 2014.
DOI : 10.1093/jac/dku173

X. Wittebole, S. De-roock, and S. M. Opal, A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens, Virulence, vol.35, issue.1, pp.226-235, 2014.
DOI : 10.1371/journal.pone.0004944

A. Wright, C. H. Hawkins, E. E. Anggard, and D. R. Harper, ; a preliminary report of efficacy, Clinical Otolaryngology, vol.8, issue.4, pp.349-357, 2009.
DOI : 10.3201/eid0809.020063

R. Young and J. J. Gill, Phage therapy redux--What is to be done?, Science, vol.22, issue.44, pp.1163-1164, 2015.
DOI : 10.1073/pnas.1508355112